X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CARDIOVASCULAR DRUGS AND THERAPY

期刊標題檢索 CARDIOVASC DRUG 最新評論: How long has editorinvited been invited? (2024-10-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CARDIOVASCULAR DRUGS AND THERAPY]您好,您是該頁面的第 31384 位訪客。

期刊簡介
期刊名稱CARDIOVASCULAR DRUGS AND THERAPY CARDIOVASCULAR DRUGS AND THERAPY
LetPub Score
7.5
50 ratings
Rate

Reputation
8.8

Influence
6.1

Speed
9.1

期刊簡稱CARDIOVASC DRUG THER
ISSN0920-3206
E-ISSN1573-7241
h-index63
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.300.9730.814
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q135 / 272
Category: Medicine
Subcategory: Cardiology and Cardiovascular Medicine
Q157 / 387
Category: Medicine
Subcategory: Pharmacology
Q165 / 313

自引率 (2023-2024)3.20%自引率趨勢
掲載範囲
Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.
官方網站https://www.springer.com/10557
在線稿件提交https://www.editorialmanager.com/cdty/
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1987
每年文章數101每年文章數趨勢
黃金OA百分比26.52%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CARDIAC & CARDIOVASCULAR SYSTEMSSCIEQ267/220
PHARMACOLOGY & PHARMACYSCIEQ2126/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0920-3206%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 4.5 Month(s)
競爭力 *來自作者的數據: About 67.5%
參考鏈接
相關期刊 【CARDIOVASCULAR DRUGS AND THERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews CardiologyH-index: 105

    CiteScore: 53.10
    EUROPEAN HEART JOURNALH-index: 265

    CiteScore: 39.30
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYH-index: 394

    CiteScore: 42.70
    EUROPEAN JOURNAL OF HEART FAILUREH-index: 119

    CiteScore: 27.30
    CARDIOVASCULAR RESEARCHH-index: 202

    CiteScore: 21.50
    Circulation-Arrhythmia and ElectrophysiologyH-index: 87

    CiteScore: 13.70
    EUROPACEH-index: 92

    CiteScore: 10.30
    Circulation-Heart FailureH-index: 88

    CiteScore: 12.90
    BASIC RESEARCH IN CARDIOLOGYH-index: 86

    CiteScore: 16.30
    TRENDS IN CARDIOVASCULAR MEDICINEH-index: 92

    CiteScore: 18.70
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Cardiology111407
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY106021
    CARDIOVASCULAR RESEARCH104546
    EUROPEAN HEART JOURNAL65511
    HEART57506
    CARDIOLOGY52138
    BASIC RESEARCH IN CARDIOLOGY48319
    AMERICAN JOURNAL OF CARDIOLOGY46707
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY44813
    CLINICAL CARDIOLOGY39958
  •  

    CARDIOVASCULAR DRUGS AND THERAPY CARDIOVASCULAR DRUGS AND THERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CARDIOVASCULAR DRUGS AND THERAPY] 的評論撰寫評論
作者: 活人玟玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 18:51:37 評論於
How long has editorinvited been invited?
(0) 讚! | 活人玟玉

作者: 南川傲南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 19:45:19 評論於
Is the external audit fast?
(0) 讚! | 南川傲南

作者: 南川傲南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 14:12:39 評論於
May I ask, how fast is the review process?
(0) 讚! | 南川傲南

作者: 邻家困顿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-17 12:50:06 評論於
This is an article in a scientific journal.
(0) 讚! | 邻家困顿

作者: 巴蜀亦竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-12 13:09:41 評論於
Currently in the process of investing
(0) 讚! | 巴蜀亦竹

作者: 四风寄容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-08 19:12:58 評論於
Does anyone know if this routine article is a regular experimental article?
(0) 讚! | 四风寄容

作者: Simon Kent


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-17 20:38:48 評論於
Could you please translate the following paragraph into English and Japanese?
(0) 讚! | Simon Kent

作者: 螳螂光泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-09 19:16:28 評論於
Boss, have you won the lottery? How long does this manuscript review take?
(0) 讚! | 螳螂光泽

作者: 北国半蕾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-23 23:05:59 評論於
Is this magazine available only online?
(0) 讚! | 北国半蕾

作者: 北国半蕾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-23 13:12:47 評論於
Excuse me, how much is the magazine advertising fee?
(0) 讚! | 北国半蕾

作者: 風見奕诺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-19 23:02:08 評論於
How is it going? It's been 2 weeks since I revised it, and I'm anxiously waiting
(0) 讚! | 風見奕诺

作者: 風見奕诺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-19 11:37:20 評論於
How did it go later?
(0) 讚! | 風見奕诺

作者: 风神慧青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-28 16:14:29 評論於
How long does it usually take to receive the internet? I haven't heard anything yet, and I'm getting anxious
(0) 讚! | 风神慧青

作者: 苍风思聪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-02 11:56:48 評論於
It's a mistake. It should be 1.5m
(0) 讚! | 苍风思聪

作者: 苍风思聪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-01 21:49:49 評論於
Research focus: Cardiovascular experience sharing: Submitted a paper for the first review, 1.5 hours for major revision, one reviewer gave minor revisions with acceptance, and another provided good suggestions for improvement. After revising for 2.5 weeks, only one reviewer had a small question, but the editor-in-chief got angry and pointed out poor English, requiring another major revision. Considering the journal under springnature, I decided to use their editing service (PS: shinewrite had previously edited the paper twice). After revising, it was rejected 2 days later. The editor-in-chief said poor writing. Feeling upset, not sure what to say
(0) 讚! | 苍风思聪

作者: 北冥碧琳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-27 08:25:32 評論於
Under review for a week, hoping for good luck, waiting for this article to graduate next year
(0) 讚! | 北冥碧琳

作者: Mamie Tours


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-15 22:23:38 評論於
Today a new article was submitted, with a 20% acceptance rate for the middle draft. I hope the magazine will review it soon
(0) 讚! | Mamie Tours

作者: 蓉沼迁迁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-02 09:47:21 評論於
Couldn't hold steady, fell below 4
(0) 讚! | 蓉沼迁迁

作者: 金顶书柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-28 18:11:51 評論於
Do I need to scan and upload an ethics review or informed consent form for this magazine?
(0) 讚! | 金顶书柔

作者: 金顶书柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-28 10:04:42 評論於
Do we need to upload the ethics review or informed consent form for this magazine?
(0) 讚! | 金顶书柔

作者: LetPub163


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2020-12-13 17:37:21 評論於
The review speed is very fast, and the reviewers gave some friendly opinions. After underwent a major revision and a minor revision, it finally got accepted. There was no page fee, and it is recommended to submit.

(3) 讚! | LetPub163

作者: 疯魔壬戌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-09 11:26:09 評論於
Review speed: 1.0 | Submission success rate: 75.0 Emphasis on research direction: Clinical drug metabolism Experience sharing: Submitted on October 20, 2020, accepted on December 10, minor revisions. After resubmission, accepted within 3 working days, reviewers are very professional, providing constructive and friendly suggestions that help improve the content of the article. They are the type of reviewers that will help you find relevant references. Language requirements may be strict, so it is recommended to polish the article before resubmitting
(0) 讚! | 疯魔壬戌

作者: 应龙梦泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-04 11:33:48 評論於
Can you share the review cycle, please? Thank you very much
(0) 讚! | 应龙梦泽

作者: 应龙梦泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-04 08:18:57 評論於
Can you share the review period, thank you
(0) 讚! | 应龙梦泽

作者: 是你的亚鑫呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-19 17:21:45 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: The magazine feels very fast in reviewing, the comments given are pertinent, and many people around me have been accepted. We must maintain a stable Impact Factor!
(0) 讚! | 是你的亚鑫呀

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CARDIOVASCULAR DRUGS AND THERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*